课题基金 / 基金详情

Development of Gene Therapy with Nanotechnology derived Intelligent Drug Deliver Systems

Development of Gene Therapy with Nanotechnology derived Intelligent Drug Deliver Systems
利用纳米技术衍生的智能药物输送系统开发基因治疗
批准号:
15390389
负责人:
YANAGIE Hironobu
金额:
$9.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

YANAGIE Hironobu的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We develop polyion complex with DNA and polycation for gene delivery systems. Polyethyleneimine was selected for polycation that have protonsponde effect on transfection to cancer cells. Polyethylene-glycol binding carboxyl chain was also used for coating the cationic charged DNA/polycation complex. To increase the transfection efficacy, we also examined pH sensitive peptide, JTS-1 that constructed with analysis of Influenza virus. Polyethyleneimine and DNA complex showed 1 × 10^9 IU/mg luciferase activity. In case of coating the DNA/polyion complex with PEG-C, the luciferase activity was increase to 3 × 10^9 IU/mg, because of the compaction and incresent of stability with addition of PEG-C to complex, so the transfection efficacy was increased. When addition of JTS-1 to the DNA/polyethyleneimine/lactose-binding PEG-C complex, it is easily to escape the lysis of lysosome and transfect the DNA to cytoplasm, and 6 × 10^9 IU/mg luciferase activity was obtained. Increasing of transfection efficacy of β-gal gene by intratumor injection of β-gal DNA plasmid/Polyethyleneimine/lactose-binding PEG-C/JTS-1 complex on gastric cancer tumor bearing mice model.According to the analysis of DNA microarray with ancer cell lines that were sensitive or resistant to Oxaliplatin or Cisplatin, Tubrin specific Chaperon E gene and CBP/P300-interacting transactivator (CITED2) gene were increased on Oxaliplatin or Cisplatin resistant cancer cells.
期刊论文(35)
专著(0)
科研奖励(0)
会议论文
Kazuo Maruyama: "Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin."Pharmaceutical Research. 25. 275-279 (2003)
Kazuo Maruyama:“通过带有聚乙二醇偶联转铁蛋白的脂质体靶向大鼠缺血后脑内皮。”药物研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuo Maruyama: "Intracellular targeting of sodium mercaptoundecahydrododecaborate (BHS) to solid tumors by transferring-PEG liposomes, for boron neutron-capture therapy (BNCT)"J.Control.Release. (in press). (2004)
Kazuo Maruyama:“通过转移 PEG 脂质体将巯基十一氢十二硼酸钠 (BHS) 细胞内靶向实体瘤,用于硼中子捕获疗法 (BNCT)”J.Control.Release。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Intracellular targeting of sodium mercaptoundecahydrododecaborate(BSH)to solid tumors by transferring-PEG liposomes, for boron neutron-capture therapy (BNCT)
通过转移 PEG 脂质体将巯基十一氢十二硼酸钠 (BSH) 细胞内靶向实体瘤,用于硼中子俘获疗法 (BNCT)
DOI: --
发表时间: 2004
期刊: J.Control.Release Vol.98 No.2
影响因子: --
作者: [Hironobu Yanagie, Kazuo Maruyama]
通讯作者: Kazuo Maruyama
Intracellular targeting of sodium mercaptoundecathydrododecaborate(BHS)to solid tumors by transferring-PEG liposomes,for boron neutron-capture therapy (BNCT)
通过转移 PEG 脂质体将巯基十一氢十二硼酸钠 (BHS) 细胞内靶向实体瘤,用于硼中子俘获疗法 (BNCT)
DOI: --
发表时间: 2004
期刊: J.Control.Release 98,(2)
影响因子: --
作者: [Matsumoto S, et al., Yoden E, Matsumoto K. et al., Zamora CA, 松本慎一, Matsumoto K, Yamamoto T, Kuroki H, Kazuo Maruyama]
通讯作者: Kazuo Maruyama
16
    Development of Intelligent Gadorinium Neutron Capture Therapy asCancer Specific Atomic Suppression Therapy
    • 批准号:
      23659639
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      YANAGIE Hironobu
    • 依托单位:
    Molecular Targeting Therapy with Intelligent Drug Delivery System using Transporter
    • 批准号:
      13557104
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.96万
    • 财政年份:
      2001
    • 负责人:
      YANAGIE Hironobu
    • 依托单位:
    Development of New Strategy of Boron Neutron Capture Therapy to Cancer Combined with Tumor Specific Gene Delivery
    International Collaboration for Application of Boron Neutron Capture Therapy to Intraoperative Irradiational Therapy